Literature DB >> 19373429

Cancer cells spread through lymph vessels in the submucosal layer of the common bile duct in gallbladder carcinoma.

Akira Chikamoto1, Tatsuya Tsuji, Osamu Nakahara, Yasuo Sakamoto, Yoshiaki Ikuta, Hiroshi Tanaka, Hiroshi Takamori, Masahiko Hirota, Keiichiro Kanemitsu, Hideo Baba.   

Abstract

INTRODUCTION: In the present study, we performed immunohistochemical staining with a lymphatic epithelium-specific marker, D2-40, to analyze the status of lymphatic spreading in the hepatoduodenal ligament in T2 gallbladder carcinoma (GC).
METHODS: One hundred and eighty-six paraffin-embedded specimens from 15 T2 GC patients were reviewed.
RESULTS: Lymph vessels lined with D2-40 were visualized in the submucosal layer of the common bile duct in all cases. In 3 of 15 patients, clusters of cancer cells were identified in the submucosal lymph vessels of the extrahepatic bile duct, and this lymphatic invasion of cancer cells failed to be detected with only conventional hematoxylin-eosin staining. The frequency of the invasion to the submucosal lymph vessels in T2 GC correlated with presence of microscopic invasion to hepatoduodenal ligament and perineural invasion.
CONCLUSION: There were lymph vessels in the submucosal layer of the common bile duct, and cancer cells can spread through these channels in addition to the large lymph vessels in subserosal layer around the extrahepatic bile duct in GC. The present results would support the concept of en bloc resection of the extrahepatic bile duct in curative resection for T2 GC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373429     DOI: 10.1007/s00534-009-0101-y

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  8 in total

1.  Patterns of recurrence after resection of gallbladder cancer without routine extrahepatic bile duct resection.

Authors:  Jimme K Wiggers; Bas Groot Koerkamp; Zachri Ovadia; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2013-11-07       Impact factor: 3.647

2.  Combined extrahepatic bile duct resection for locally advanced gallbladder carcinoma: does it work?

Authors:  Tsuyoshi Igami; Tomoki Ebata; Yukihiro Yokoyama; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Yoshie Shimoyama; Masato Nagino
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

3.  Effect of reoperation on long-term outcome of pT1b/T2 gallbladder carcinoma after initial laparoscopic cholecystectomy.

Authors:  Tae-Yong Ha; Young-In Yoon; Shin Hwang; Ye-Jong Park; Sung-Hwa Kang; Bo-Hyun Jung; Wan-Joon Kim; Min-Ho Sin; Chul-Soo Ahn; Deok-Bog Moon; Gi-Won Song; Dong-Hwan Jung; Young-Joo Lee; Kwang-Min Park; Ki-Hun Kim; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2014-11-06       Impact factor: 3.452

4.  Rapidly progressive subcutaneous metastases from gallbladder cancer: insight into a rare presentation in gastrointestinal malignancies.

Authors:  Sean F Heavey; Eric J Roeland; Ann M Ponsford Tipps; Brian Datnow; Jason K Sicklick
Journal:  J Gastrointest Oncol       Date:  2014-08

5.  Survival analysis following resection of AJCC stage III gallbladder carcinoma based on different combinations of T and N stages.

Authors:  Kyoung-Yeon Hwang; Young-In Yoon; Shin Hwang; Tae-Yong Ha; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Gi-Won Song; Dong-Hwan Jung; Young-Joo Lee; Kwang-Min Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2015-02-28

6.  Is combined extra-hepatic bile-duct resection justified for advanced gallbladder carcinoma?

Authors:  Jun-Ke Wang; Wen-Jie Ma; Zhen-Ru Wu; Qin Yang; Hai-Jie Hu; Fei Liu; Fu-Yu Li
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-05-25

7.  Axillary nodal metastasis of operated gallbladder carcinoma: remote site of aggression-a case report.

Authors:  Manu Vats; Lovenish Bains; Pawan Lal; Shramana Mandal
Journal:  BMC Surg       Date:  2022-01-15       Impact factor: 2.102

8.  Clinicopathological Differences in T2 Gallbladder Cancer According to Tumor Location.

Authors:  Wan-Joon Kim; Tae-Wan Lim; Pyoung-Jae Park; Sae-Byeol Choi; Wan-Bae Kim
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.